These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8363392)

  • 81. Clinical efficacy of Cefuroxime axetil in S. typhi.
    Mathur YC; Mathur NC; Lal HM
    Indian Pediatr; 1996 Dec; 33(12):1033-7. PubMed ID: 9141805
    [No Abstract]   [Full Text] [Related]  

  • 82. [Treatment of uncomplicated urinary tract infections: cefuroxime vs cotrimoxazole].
    Castrillón M; Palma I; Azócar G; Tapia R; Silva A; Pescio S; Aguayo R; Triantafilo V; Contreras J; Thompson L
    Rev Med Chil; 1991 Aug; 119(8):913-6. PubMed ID: 1844773
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Clinical studies on enoxacin in urinary tract infection].
    Nagai N; Kaneko S; Akiyama T; Kurita T; Iguchi M; Kataoka K
    Hinyokika Kiyo; 1988 Jul; 34(7):1283-91. PubMed ID: 3051955
    [TBL] [Abstract][Full Text] [Related]  

  • 84. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media.
    Gehanno P; Lenoir G; Berche P
    Antimicrob Agents Chemother; 1995 Jan; 39(1):271-2. PubMed ID: 7695322
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cefuroxime axetil in the treatment of cutaneous infections.
    Parish LC; Cocchetto DM; Werner K; Jungkind DL; Witkowski J
    Int J Dermatol; 1987; 26(6):389-93. PubMed ID: 3305394
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Efficacy and tolerance of axetil cefuroxime for treatment of chronic urinary tract infection relapse in patients with diabetes mellitus].
    Markiewicz K; Tatoń J; Trippenbach T; Raźna I
    Pol Tyg Lek; 1996 Jan; 51(1-5):63-4. PubMed ID: 8754307
    [No Abstract]   [Full Text] [Related]  

  • 87. An open multicentre study to compare the efficacy and safety of sultamicillin with that of cefuroxime axetil in acute ear nose and throat infections in adults.
    Alvart R
    J Int Med Res; 1992; 20 Suppl 1():53A-61A. PubMed ID: 1451930
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Enoxacin in urinary tract infections associated with gynecological diseases.
    De Cecco L; Leone M
    J Chemother; 1989 Jul; 1(4 Suppl):886-7. PubMed ID: 16312687
    [No Abstract]   [Full Text] [Related]  

  • 89. The use of enoxacin in the treatment of urinary disease: a critical review of the Italian and international literature.
    Cortecchia V; Beghelli R; Bercovich E; Scarano P; Tiozzi E; Martelli A
    J Chemother; 1989 Jul; 1(4 Suppl):851-2. PubMed ID: 16312668
    [No Abstract]   [Full Text] [Related]  

  • 90. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
    Shah PM; Maesen FP; Dolmann A; Vetter N; Fiss E; Wesch R
    J Antimicrob Chemother; 1999 Apr; 43(4):529-39. PubMed ID: 10350383
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cefuroxime axetil.
    Marx MA; Fant WK
    Drug Intell Clin Pharm; 1988 Sep; 22(9):651-8. PubMed ID: 3063476
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment of otitis media with cefuroxime axetil.
    Aronovitz GH
    South Med J; 1988 Aug; 81(8):978-80. PubMed ID: 3043692
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group.
    Burke T; Villanueva C; Mariano H; Huck W; Orchard D; Haverstock D; Heyd A; Church D
    Clin Ther; 1999 Oct; 21(10):1664-77. PubMed ID: 10566563
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Bacterial and clinical evaluation of axetil cefuroxime in suspension].
    Siwińska-Gołebiowska H; Szozda G; Pawluch D; Nowakowska K; Drejewicz H; Wawrzyniak M; Czerwińska I
    Med Dosw Mikrobiol; 1994; 46(1-2):95-101. PubMed ID: 7967940
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Regional features of the microbial landscape of urine and comparative evaluation of antimicrobial therapy in children with cystitis.
    Kryuchko TO; Kharshman VP; Nesina IM; Kuzmenko NV; Oleksiienko JM
    Wiad Lek; 2017; 70(3 pt 2):566-570. PubMed ID: 28713083
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The pharmacokinetics of cefuroxime axetil in the sick elderly patient.
    Ridgway E; Stewart K; Rai G; Kelsey MC; Bielawska C
    J Antimicrob Chemother; 1991 May; 27(5):663-8. PubMed ID: 1885424
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Enoxacin: a new fluoroquinolone.
    Jaber LA; Bailey EM; Rybak MJ
    Clin Pharm; 1989 Feb; 8(2):97-107. PubMed ID: 2645085
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Sequential therapy with cefuroxime and cefuroxime-axetil for community-acquired lower respiratory tract infection in the oldest old.
    Flamaing J; Knockaert D; Meijers B; Verhaegen J; Peetermans WE
    Aging Clin Exp Res; 2008 Feb; 20(1):81-6. PubMed ID: 18283233
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
    Klein GL; Whalen E; Echols RM; Heyd A
    J Otolaryngol; 1998 Feb; 27(1):10-6. PubMed ID: 9511113
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Penetration of oral cefuroxime axetil into the human aqueous humor.
    Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
    Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.